| pubmed-article:19885117 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19885117 | lifeskim:mentions | umls-concept:C0011860 | lld:lifeskim |
| pubmed-article:19885117 | lifeskim:mentions | umls-concept:C0205103 | lld:lifeskim |
| pubmed-article:19885117 | lifeskim:mentions | umls-concept:C0021641 | lld:lifeskim |
| pubmed-article:19885117 | lifeskim:mentions | umls-concept:C0162621 | lld:lifeskim |
| pubmed-article:19885117 | lifeskim:mentions | umls-concept:C0002045 | lld:lifeskim |
| pubmed-article:19885117 | lifeskim:mentions | umls-concept:C1998548 | lld:lifeskim |
| pubmed-article:19885117 | lifeskim:mentions | umls-concept:C0682002 | lld:lifeskim |
| pubmed-article:19885117 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:19885117 | pubmed:dateCreated | 2009-11-3 | lld:pubmed |
| pubmed-article:19885117 | pubmed:abstractText | Until recently, titration of insulin in type 2 diabetes clinical trials was typically left up to the investigator's discretion with a simple statement of the target ranges for glucose. In type 2 diabetes trials the average glycemic control achieved was usually less than desirable. Since then a number of trials have been conducted and reported utilizing various algorithms under various conditions. The objective of this article is to provide a review of the evidence to date. | lld:pubmed |
| pubmed-article:19885117 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19885117 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19885117 | pubmed:status | PubMed-not-MEDLINE | lld:pubmed |
| pubmed-article:19885117 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:19885117 | pubmed:issn | 1932-2968 | lld:pubmed |
| pubmed-article:19885117 | pubmed:author | pubmed-author:StrangePoulP | lld:pubmed |
| pubmed-article:19885117 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19885117 | pubmed:volume | 1 | lld:pubmed |
| pubmed-article:19885117 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19885117 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19885117 | pubmed:pagination | 540-8 | lld:pubmed |
| pubmed-article:19885117 | pubmed:dateRevised | 2010-9-27 | lld:pubmed |
| pubmed-article:19885117 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:19885117 | pubmed:articleTitle | Treat-to-target insulin titration algorithms when initiating long or intermediate acting insulin in type 2 diabetes. | lld:pubmed |
| pubmed-article:19885117 | pubmed:affiliation | Poul Strange Consulting LLC, Princeton Junction, New Jersey 08550, USA. pstrange@verizon.net | lld:pubmed |
| pubmed-article:19885117 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19885117 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19885117 | lld:pubmed |
